Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $686K | ﹤0.01% |
9,300
-356,500
| -97% | -$26.6M |
|
2552
Innovator US Equity Power Buffer ETF August
PAUG
$864M
| $686K | ﹤0.01% |
+22,100
| New | +$699K |
|
2553
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$924M
| $685K | ﹤0.01% |
16,500
+8,401
| +104% | +$357K |
|
2554
iShares ESG Optimized MSCI USA ETF
SUSA
$4.15B
| $684K | ﹤0.01% |
7,600
+3,200
| +73% | +$301K |
|
|
GTHX
2555
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $683K | ﹤0.01% |
474,080
-97,711
| -17% | -$189K |
|
2556
Cohen & Steers
CNS
$4.34B
| $681K | ﹤0.01% |
10,870
-72,259
| -87% | -$4.57M |
|
2557
Backblaze
BLZE
$1.12B
| $680K | ﹤0.01% |
123,616
+20,516
| +20% | +$111K |
|
2558
State Street SPDR Dow Jones REIT ETF
RWR
$1.96B
| $680K | ﹤0.01% |
+8,200
| New | +$737K |
|
|
GHL
2559
DELISTED
Greenhill & Co., Inc.
GHL
| $680K | ﹤0.01% |
45,973
-1,027
| -2% | -$15.1K |
|
2560
Ponce Financial Group
PDLB
$487M
| $679K | ﹤0.01% |
86,794
-15,700
| -15% | -$135K |
|
2561
CVD Equipment Corp
CVV
$57.9M
| $678K | ﹤0.01% |
101,882
-1,700
| -2% | -$12.2K |
|
2562
Bio-Rad Laboratories Class B
BIO.B
| $675K | ﹤0.01% |
1,900
| – | – |
|
|
CODX
2563
Co-Diagnostics
CODX
$5.23M
| $675K | ﹤0.01% |
21,213
-577
| -3% | -$21.8K |
|
2564
American Coastal Insurance
ACIC
$498M
| $674K | ﹤0.01% |
91,626
-16,100
| -15% | -$104K |
|
2565
Bristow Group
VTOL
$1.33B
| $670K | ﹤0.01% |
23,800
+5,500
| +30% | +$159K |
|
2566
FIVE9
FIVN
$2.17B
| $669K | ﹤0.01% |
10,400
-200,498
| -95% | -$15M |
|
2567
Personalis
PSNL
$1.39B
| $668K | ﹤0.01% |
552,475
+100,275
| +22% | +$179K |
|
2568
C4 Therapeutics
CCCC
$402M
| $666K | ﹤0.01% |
357,988
-158,910
| -31% | -$485K |
|
2569
Marcus & Millichap
MMI
$1.2B
| $666K | ﹤0.01% |
22,700
-68,900
| -75% | -$2.31M |
|
|
KALV
2570
DELISTED
KalVista Pharmaceuticals
KALV
| $665K | ﹤0.01% |
69,100
-73,828
| -52% | -$754K |
|
2571
Moog Inc Class B
MOG.B
$13.1B
| $665K | ﹤0.01% |
5,900
+100
| +2% | +$11.3K |
|
|
ACCS
2572
ACCESS Newswire
ACCS
$26.1M
| $665K | ﹤0.01% |
35,358
+620
| +2% | +$12.5K |
|
|
MCW
2573
DELISTED
Mister Car Wash
MCW
| $662K | ﹤0.01% |
+120,200
| New | +$917K |
|
2574
Spero Therapeutics
SPRO
$73.5M
| $662K | ﹤0.01% |
547,165
-46,266
| -8% | -$64.1K |
|
2575
MaxCyte
MXCT
$119M
| $659K | ﹤0.01% |
211,100
+135,400
| +179% | +$544K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.